Randomised clinical trials of drug treatment for chronic heart failure are the basis of many
physicians' beliefs about heart failure. Due to the selection bias of such studies—which …

Objectives: This study evaluated gender differences in clinical characteristics, treatment and
outcome among patients with heart failure, and to what extent these differences are due to …

The prevalence of chronic heart failure (CHF) is steadily increasing. Both sexes are affected,
with significant differences in etiology, epidemiology and clinical presentation, prognosis …

Heart failure (HF) numbers continue to grow in the United States and approximately 50% of
patients living with HF are women. For the provider, it is critical to understand the role that …

Sex-based differences exist in risk, symptoms, and management of heart failure (HF).
Women have a higher incidence of HF with preserved ejection fraction compared with men …

Background Heart failure (HF) is an increasing problem for the aging population, specifically
among women. The etiology of HF influences both the selection and outcome of the …

Heart failure (HF) is a complex disease, almost as common in women as in men.
Nonetheless, HF clinical presentation, prognosis, and aetiology vary by sex. This review …

Background Unlike other cardiovascular diseases the incidence and prevalence of
congestive heart failure (CHF) continues to increase. While gender differences in coronary …

Women exhibit distinct differences compared with men in regard to epidemiology, risk
factors, causes, mechanisms for disease development, response to treatment, and outcomes …

In recent clinical trials of medical therapy for heart failure, only 20% of patients enrolled were
women. The reasons for the low enrollment of women have not been clear. Although the …